210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuromuscular Disorders

• Publication date

  2015-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nmd.2015.06.462PMID 26206601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis

  2015cited by this paper
• Neurofilament light chain

  2015cited by this paper
• A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis

  2015influential reference
• A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

  2015cited by this paper
• Training improves oxidative capacity, but not function, in spinal muscular atrophy type III

  2015cited by this paper
• Brugada syndrome in spinal and bulbar muscular atrophy

  2014cited by this paper
• Electrical impedance myography correlates with standard measures of Als severity

  2014influential reference
• Human Adipose-Derived Mesenchymal Stem Cells as a New Model of Spinal and Bulbar Muscular Atrophy

  2014cited by this paper
• Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool

  2014cited by this paper
• Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy

  2014cited by this paper
• Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy

  2014cited by this paper
• Correlation of clinical and molecular features in spinal bulbar muscular atrophy

  2014cited by this paper
• Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.

  2014cited by this paper
• Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

  2014cited by this paper
• Multi-Parametric Spinal Cord MRI as Potential Progression Marker in Amyotrophic Lateral Sclerosis

  2014influential reference
• Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy

  2014cited by this paper
• New Routes to Therapy for Spinal and Bulbar Muscular Atrophy

  2013cited by this paper
• Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study

  2013cited by this paper
• 7‐T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis

  2013influential reference
• 196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands.

  2013cited by this paper
• No evidence of cardiomyopathy in spinal and bulbar muscular atrophy

  2013cited by this paper
• Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy

  2013cited by this paper
• Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy

  2013cited by this paper
• Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures.

  2012cited by this paper
• Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins.

  2012cited by this paper
• Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy.

  2012cited by this paper
• Cross‐sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy

  2012cited by this paper
• Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY

  2011cited by this paper
• Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

  2011cited by this paper
• Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

  2011cited by this paper
• 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy.

  2011cited by this paper
• Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy

  2011cited by this paper
• Multipoint incremental motor unit number estimation as an outcome measure in ALS

  2011cited by this paper
• Mitochondrial DNA damage in spinal and bulbar muscular atrophy patients and carriers.

  2010cited by this paper
• A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases

  2010cited by this paper
• Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.

  2010cited by this paper
• B2 attenuates polyglutamine‐expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy

  2010cited by this paper
• Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.

  2010cited by this paper
• Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.

  2010cited by this paper
• Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.

  2009cited by this paper
• Specific N-terminal mutations in the human androgen receptor induce cytotoxicity.

  2009influential reference
• Standard and modified statistical mune evaluations in spinal‐bulbar muscular atrophy

  2009cited by this paper
• Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy

  2009cited by this paper
• Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.

  2009cited by this paper
• Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)

  2009cited by this paper
• The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy

  2009cited by this paper
• Electrical impedance myography as a biomarker for ALS.

  2009influential reference
• Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk

  2009cited by this paper
• Mitochondrial abnormalities in spinal and bulbar muscular atrophy

  2008cited by this paper
• Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS

  2008influential reference
• Walking capacity evaluated by the 6‐minute walk test in spinal and bulbar muscular atrophy

  2008cited by this paper
• Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.

  2008cited by this paper
• Adapting Proteostasis for Disease Intervention

  2008cited by this paper
• Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy.

  2007cited by this paper
• Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

  2007cited by this paper
• HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

  2007cited by this paper
• Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease

  2007cited by this paper
• Elevated creatine kinase and transaminases in asymptomatic SBMA

  2007cited by this paper
• Bayesian statistical MUNE method

  2007cited by this paper
• Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.

  2006cited by this paper
• Motor Unit Number Estimation—A Bayesian Approach

  2006cited by this paper
• Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model.

  2006cited by this paper
• Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.

  2005cited by this paper
• The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons.

  2004cited by this paper
• Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.

  2004cited by this paper
• Muscle MRI findings of X-linked spinal and bulbar muscular atrophy.

  2004cited by this paper
• Castration Restores Function and Neurofilament Alterations of Aged Symptomatic Males in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy

  2004cited by this paper
• Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease

  2004influential reference
• Motor unit number index (MUNIX)

  2004cited by this paper
• Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768−773

  2003cited by this paper
• Heat Shock Protein 70 Chaperone Overexpression Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model by Reducing Nuclear-Localized Mutant Androgen Receptor Protein

  2003cited by this paper
• Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

  2003cited by this paper
• Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.

  2002cited by this paper
• Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motoneuronal processes

  2002cited by this paper
• Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular Atrophy*

  2002cited by this paper
• Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women.

  2002cited by this paper
• Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.

  2002cited by this paper
• A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length.

  2002cited by this paper
• Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

  2002cited by this paper
• Localized bioimpedance analysis in the evaluation of neuromuscular disease

  2002cited by this paper
• Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy.

  2001cited by this paper
• Roles of the heat shock transcription factors in regulation of the heat shock response and beyond

  2001cited by this paper
• Chaperones Hsp70 and Hsp40 Suppress Aggregate Formation and Apoptosis in Cultured Neuronal Cells Expressing Truncated Androgen Receptor Protein with Expanded Polyglutamine Tract*

  2000cited by this paper
• Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract.

  2000cited by this paper
• Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.

  1999cited by this paper
• The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function

  1999influential reference
• The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

  1999cited by this paper
• Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy

  1998cited by this paper
• Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system.

  1997cited by this paper
• Electrical and mechanical properties of skeletal muscle underlying increased fatigue in patients with amyotrophic lateral sclerosis

  1996cited by this paper
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

  1991cited by this paper
• Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.

  1968cited by this paper

• Non-invasive Techniques for Muscle Fatigue Monitoring: A Comprehensive Survey

  2024cites this paper
• 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands.

  2024cites this paper
• The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA)

  2023cites this paper
• The French national protocol for Kennedy’s disease (SBMA): consensus diagnostic and management recommendations

  2020cites this paper
• Spinal and bulbar muscular atrophy with pseudomyotonia phenomena: a clinical case report

  2020cites this paper
• Towards a European unifying lab for Kennedy ’ s Disease 15-17 th February , 2019 Hoofddorp , The Netherlands

  2019cites this paper
• 241st ENMC international workshop: Towards a European unifying lab for Kennedy's disease. 15-17th February, 2019 Hoofddorp, The Netherlands.

  2019cites this paper
• The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage

  2018cites this paper
• Biomarkers for Detecting Mitochondrial Disorders

  2018cites this paper
• The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy

  2018cites this paper
• Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review

  2018cites this paper
• Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.

  2017cites this paper
• Wet, volatile, and dry biomarkers of exercise-induced muscle fatigue

  2016cites this paper
• Clinical Trials in Spinal and Bulbar Muscular Atrophy—Past, Present, and Future

  2016cites this paper
• Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure

  2016cites this paper
• Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy

  2016cites this paper
• Towards a European Registry and Biorepository for Patients with Spinal and Bulbar Muscular Atrophy

  2016cites this paper
• Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy

  2016cites this paper